United States T-Cell Immunotherapy Industry 2017 Market Research Report

 Table of Contents

United States T-Cell Immunotherapy Market Report 2017
1 T-Cell Immunotherapy Overview
    1.1 Product Overview and Scope of T-Cell Immunotherapy
    1.2 Classification of T-Cell Immunotherapy
        1.2.1 CAR-T
        1.2.2 TCR
        1.2.3 TIL Therapies
    1.3 Application of T-Cell Immunotherapy
        1.3.1 Hematological Malignancies
        1.3.2 Solid Tumors
        1.3.3 Others
    1.4 United States Market Size Sales (Volume) and Revenue (Value) of T-Cell Immunotherapy (2012-2022)
        1.4.1 United States T-Cell Immunotherapy Sales and Growth Rate (2012-2022)
        1.4.2 United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)

2 United States T-Cell Immunotherapy Competition by Manufacturers
    2.1 United States T-Cell Immunotherapy Sales and Market Share of Key Manufacturers (2015 and 2016)
    2.2 United States T-Cell Immunotherapy Revenue and Share by Manufactures (2015 and 2016)
    2.3 United States T-Cell Immunotherapy Average Price by Manufactures (2015 and 2016)
    2.4 T-Cell Immunotherapy Market Competitive Situation and Trends
        2.4.1 T-Cell Immunotherapy Market Concentration Rate
        2.4.2 T-Cell Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion

3 United States T-Cell Immunotherapy Sales (Volume) and Revenue (Value) by States (2012-2017)
    3.1 United States T-Cell Immunotherapy Sales and Market Share by States (2012-2017)
    3.2 United States T-Cell Immunotherapy Revenue and Market Share by States (2012-2017)
    3.3 United States T-Cell Immunotherapy Price by States (2012-2017)

4 United States T-Cell Immunotherapy Sales (Volume) and Revenue (Value) by Type (2012-2017)
    4.1 United States T-Cell Immunotherapy Sales and Market Share by Type (2012-2017)
    4.2 United States T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
    4.3 United States T-Cell Immunotherapy Price by Type (2012-2017)
    4.4 United States T-Cell Immunotherapy Sales Growth Rate by Type (2012-2017)

5 United States T-Cell Immunotherapy Sales (Volume) by Application (2012-2017)
    5.1 United States T-Cell Immunotherapy Sales and Market Share by Application (2012-2017)
    5.2 United States T-Cell Immunotherapy Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 United States T-Cell Immunotherapy Manufacturers Profiles/Analysis
    6.1 Adaptimmune
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.1.2.1 CAR-T
            6.1.2.2 TCR
        6.1.3 Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Altor Bioscience Corporation
        6.2.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.2.2.1 CAR-T
            6.2.2.2 TCR
        6.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Cellectis
        6.3.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.3.2.1 CAR-T
            6.3.2.2 TCR
        6.3.3 Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cell Therapy Catapult
        6.4.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.4.2.1 CAR-T
            6.4.2.2 TCR
        6.4.3 Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Juno Therapeutics
        6.5.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.5.2.1 CAR-T
            6.5.2.2 TCR
        6.5.3 Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Kite Pharma
        6.6.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.6.2.1 CAR-T
            6.6.2.2 TCR
        6.6.3 Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Novartis
        6.7.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.7.2.1 CAR-T
            6.7.2.2 TCR
        6.7.3 Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Takara Bio
        6.8.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.8.2.1 CAR-T
            6.8.2.2 TCR
        6.8.3 Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Unum Therapeutics
        6.9.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.9.2.1 CAR-T
            6.9.2.2 TCR
        6.9.3 Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Abingworth
        6.10.2 T-Cell Immunotherapy Product Type, Application and Specification
            6.10.2.1 CAR-T
            6.10.2.2 TCR
        6.10.3 Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 ARCH Venture Partners
    6.12 Acorn Campus Ventures
    6.13 Adaptimmune
    6.14 AFA F?rs?kring
    6.15 AGF Private Equity
    6.16 AgonOx
    6.17 Agreen Biotech
    6.18 Aju IB Investment
    6.19 Alaska Permanent Fund
    6.20 Alexandria Ventures
    6.21 Allos Therapeutics
    6.22 Amgen
    6.23 Applied Immune Technologies
    6.24 Aquilo Capital Management

7 T-Cell Immunotherapy Manufacturing Cost Analysis
    7.1 T-Cell Immunotherapy Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of T-Cell Immunotherapy

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 T-Cell Immunotherapy Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States T-Cell Immunotherapy Market Forecast (2017-2022)
    11.1 United States T-Cell Immunotherapy Sales, Revenue Forecast (2017-2022)
    11.2 United States T-Cell Immunotherapy Sales Forecast by Type (2017-2022)
    11.3 United States T-Cell Immunotherapy Sales Forecast by Application (2017-2022)
    11.4 T-Cell Immunotherapy Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    Methodology
    Analyst Introduction
    Data Source

List of Tables and Figures 

    Figure Picture of T-Cell Immunotherapy
    Table Classification of T-Cell Immunotherapy
    Figure United States Sales Market Share of T-Cell Immunotherapy by Type in 2015
    Figure CAR-T Picture
    Figure TCR Picture
    Figure TIL Therapies Picture
    Table Application of T-Cell Immunotherapy
    Figure United States Sales Market Share of T-Cell Immunotherapy by Application in 2015
    Figure Hematological Malignancies Examples
    Figure Solid Tumors Examples
    Figure Others Examples
    Figure United States T-Cell Immunotherapy Sales and Growth Rate (2012-2022)
    Figure United States T-Cell Immunotherapy Revenue and Growth Rate (2012-2022)
    Table United States T-Cell Immunotherapy Sales of Key Manufacturers (2015 and 2016)
    Table United States T-Cell Immunotherapy Sales Share by Manufacturers (2015 and 2016)
    Figure 2015 T-Cell Immunotherapy Sales Share by Manufacturers
    Figure 2016 T-Cell Immunotherapy Sales Share by Manufacturers
    Table United States T-Cell Immunotherapy Revenue by Manufacturers (2015 and 2016)
    Table United States T-Cell Immunotherapy Revenue Share by Manufacturers (2015 and 2016)
    Table 2015 United States T-Cell Immunotherapy Revenue Share by Manufacturers
    Table 2016 United States T-Cell Immunotherapy Revenue Share by Manufacturers
    Table United States Market T-Cell Immunotherapy Average Price of Key Manufacturers (2015 and 2016)
    Figure United States Market T-Cell Immunotherapy Average Price of Key Manufacturers in 2015
    Figure T-Cell Immunotherapy Market Share of Top 3 Manufacturers
    Figure T-Cell Immunotherapy Market Share of Top 5 Manufacturers
    Table United States T-Cell Immunotherapy Sales by States (2012-2017)
    Table United States T-Cell Immunotherapy Sales Share by States (2012-2017)
    Figure United States T-Cell Immunotherapy Sales Market Share by States in 2015
    Table United States T-Cell Immunotherapy Revenue and Market Share by States (2012-2017)
    Table United States T-Cell Immunotherapy Revenue Share by States (2012-2017)
    Figure Revenue Market Share of T-Cell Immunotherapy by States (2012-2017)
    Table United States T-Cell Immunotherapy Price by States (2012-2017)
    Table United States T-Cell Immunotherapy Sales by Type (2012-2017)
    Table United States T-Cell Immunotherapy Sales Share by Type (2012-2017)
    Figure United States T-Cell Immunotherapy Sales Market Share by Type in 2015
    Table United States T-Cell Immunotherapy Revenue and Market Share by Type (2012-2017)
    Table United States T-Cell Immunotherapy Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of T-Cell Immunotherapy by Type (2012-2017)
    Table United States T-Cell Immunotherapy Price by Type (2012-2017)
    Figure United States T-Cell Immunotherapy Sales Growth Rate by Type (2012-2017)
    Table United States T-Cell Immunotherapy Sales by Application (2012-2017)
    Table United States T-Cell Immunotherapy Sales Market Share by Application (2012-2017)
    Figure United States T-Cell Immunotherapy Sales Market Share by Application in 2015
    Table United States T-Cell Immunotherapy Sales Growth Rate by Application (2012-2017)
    Figure United States T-Cell Immunotherapy Sales Growth Rate by Application (2012-2017)
    Table Adaptimmune Basic Information List
    Table Adaptimmune T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Figure Adaptimmune T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Altor Bioscience Corporation Basic Information List
    Table Altor Bioscience Corporation T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Altor Bioscience Corporation T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Cellectis Basic Information List
    Table Cellectis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Cellectis T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Cell Therapy Catapult Basic Information List
    Table Cell Therapy Catapult T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Cell Therapy Catapult T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Juno Therapeutics Basic Information List
    Table Juno Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Juno Therapeutics T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Kite Pharma Basic Information List
    Table Kite Pharma T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Kite Pharma T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Novartis Basic Information List
    Table Novartis T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Novartis T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Takara Bio Basic Information List
    Table Takara Bio T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Takara Bio T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Unum Therapeutics Basic Information List
    Table Unum Therapeutics T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Unum Therapeutics T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table Abingworth Basic Information List
    Table Abingworth T-Cell Immunotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
    Table Abingworth T-Cell Immunotherapy Sales Market Share (2012-2017)
    Table ARCH Venture Partners Basic Information List
    Table Acorn Campus Ventures Basic Information List
    Table Adaptimmune Basic Information List
    Table AFA F?rs?kring Basic Information List
    Table AGF Private Equity Basic Information List
    Table AgonOx Basic Information List
    Table Agreen Biotech Basic Information List
    Table Aju IB Investment Basic Information List
    Table Alaska Permanent Fund Basic Information List
    Table Alexandria Ventures Basic Information List
    Table Allos Therapeutics Basic Information List
    Table Amgen Basic Information List
    Table Applied Immune Technologies Basic Information List
    Table Aquilo Capital Management Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of T-Cell Immunotherapy
    Figure Manufacturing Process Analysis of T-Cell Immunotherapy
    Figure T-Cell Immunotherapy Industrial Chain Analysis
    Table Raw Materials Sources of T-Cell Immunotherapy Major Manufacturers in 2015
    Table Major Buyers of T-Cell Immunotherapy
    Table Distributors/Traders List
    Figure United States T-Cell Immunotherapy Production and Growth Rate Forecast (2017-2022)
    Figure United States T-Cell Immunotherapy Revenue and Growth Rate Forecast (2017-2022)
    Table United States T-Cell Immunotherapy Production Forecast by Type (2017-2022)
    Table United States T-Cell Immunotherapy Consumption Forecast by Application (2017-2022)
    Table United States T-Cell Immunotherapy Sales Forecast by States (2017-2022)
    Table United States T-Cell Immunotherapy Sales Share Forecast by States (2017-2022)

 

To request a free sample copy of this report, please complete the form below.

Enter captcha code*

We never share your personal data. Privacy policy